Cofactor Genomics

About:

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

Website: http://cofactorgenomics.com

Twitter/X: cofactorgenomic

Top Investors: Y Combinator, Menlo Ventures, 7percent Ventures, Silicon Valley Bank, Refactor

Description:

Cofactor Genomics is a company focused on predictive immune modeling. They aim to advance precision medicine by overcoming existing barriers. Cofactor facilitates the shift from single-analyte biomarkers to more comprehensive multidimensional biomarkers using health expression models. Their capabilities include molecular, informatic, and database tools, with one of the first CAP-certified clinical RNA sequencing laboratories. This certification helps their partners conduct clinical trials more efficiently and cost-effectively. Their expertise in molecular biology, informatics, and database management enables them to provide high-quality services to the healthcare and pharmaceutical sectors, contributing to medical research and improving patient outcomes.

Total Funding Amount:

$29M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2008-08-01

Contact Email:

info(AT)cofactorgenomics.com

Founders:

Jarret Glasscock, Ryan Richt

Number of Employees:

11-50

Last Funding Date:

2023-08-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai